Nestmedic S.A., developer of fetal well-being monitoring technology consisting of the Pregnabit Pro device and the Pregnabit Cloud platform, has signed a distribution agreement with Synektik. The Synektik Group provides IT solutions, cutting-edge technology and a full range of services and support to medical institutions in the fields of radiology, oncology, cardiology and neurology.
The object of the agreement is to grant the distributor the right to distribute and resell Pregnabit Pro devices and the licence to use the Pregnabit Cloud Platform in the agreed territory, which includes Poland, Slovakia and – from 1 September 2023 – the Czech Republic, as well as the right to offer and provide services related to the products to end users – customers or third parties operating in the aforementioned territory, including in particular implementation and maintenance services and product training. The agreement has been concluded for a period of three years, with the possibility of a further extension.
Synektik is one of the leading players in the medical equipment and radiopharmaceutical distribution market in the region. Nestmedic hopes that working with such an experienced partner will have a significant impact on the commercialisation of Pregnabit Pro.